Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How to overcome tumor resistance to anti-PD-1/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC
Li Chen, Xiaoying Jiang, Yuanheng Li, et al.
Clinical Immunology (2022) Vol. 237, pp. 108962-108962
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations
Xiang Chen, Lingjuan Chen, Xiaofei Peng, et al.
Translational Oncology (2023) Vol. 40, pp. 101851-101851
Open Access | Times Cited: 24
Pathogenetic development, diagnosis and clinical therapeutic approaches for liver metastasis from colorectal cancer (Review)
Zhenhua Jin, Yin Li, Yi Hao, et al.
International Journal of Oncology (2025) Vol. 66, Iss. 3
Closed Access | Times Cited: 1
In Situ STING‐Activating Nanovaccination with TIGIT Blockade for Enhanced Immunotherapy of Anti‐PD‐1‐Resistant Tumors
Beibei Zhang, Juan Zhang, Yaqiong Li, et al.
Advanced Materials (2023) Vol. 35, Iss. 24
Closed Access | Times Cited: 18
WTAP‐induced N6‐methyladenosine of PD‐L1 blocked T‐cell‐mediated antitumor activity under hypoxia in colorectal cancer
Qizhi Liu, Nan Zhang, Junyi Chen, et al.
Cancer Science (2024) Vol. 115, Iss. 6, pp. 1749-1762
Open Access | Times Cited: 6
Unraveling the complexities of colorectal cancer and its promising therapies – An updated review
Sayan Saha, Shreya Ghosh, Suman Ghosh, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113325-113325
Closed Access | Times Cited: 6
Combination therapy with immune checkpoint inhibitors in colorectal cancer: Challenges, resistance mechanisms, and the role of microbiota
Ali Rahimi, Zeinab Baghernejadan, Ali Hazrati, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118014-118014
Closed Access
SIRPα + CD209 + cell: a specialized antigen-presenting cell that contributes to anti-SIRPα/RT therapy in colorectal cancer
Yida Li, Weiqing Lu, Fan Xia, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access
ASCL2 induces an immune excluded microenvironment by activating cancer-associated fibroblasts in microsatellite stable colorectal cancer
Dan Zhang, Qi-Qi Ni, Qiao-Yan Liang, et al.
Oncogene (2023) Vol. 42, Iss. 38, pp. 2841-2853
Open Access | Times Cited: 11
Targeting adenosine enhances immunotherapy in MSS colorectal cancer with EGFRvIII mutation
Fei Sun, Fangzhen Yao, Chunting Zeng, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010126-e010126
Open Access
Immune Checkpoint Inhibitor-Based Combination Therapy for Colorectal Cancer: An Overview
Jingjing Li, Xuan-Fu Xu
International Journal of General Medicine (2023) Vol. Volume 16, pp. 1527-1540
Open Access | Times Cited: 10
Tumor microenvironment characterization in colorectal cancer to identify prognostic and immunotherapy genes signature
Xianwen Guo, Rong-e Lei, Qing-nan Zhou, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Immunotherapy of microsatellite stable colorectal cancer: resistance mechanisms and treatment strategies
Yan-Jie Han, Chi-Yun Shao, Ying Yao, et al.
Postgraduate Medical Journal (2024) Vol. 100, Iss. 1184, pp. 373-381
Closed Access | Times Cited: 3
Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapy
Jhen-Yu Chen, Po‐Yu Lin, Wei-Ze Hong, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 5
Open Access | Times Cited: 3
Targeting Nuclear Receptor Coactivator SRC‐1 Prevents Colorectal Cancer Immune Escape by Reducing Transcription and Protein Stability of PD‐L1
Yilin Hong, Qiang Chen, Zinan Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 33
Open Access | Times Cited: 3
Microsatellite stable metastatic colorectal cancer without liver metastasis may be preferred population for regorafenib or fruquintinib plus sintilimab as third-line or above therapy:A real-world study
Caiyun Nie, Huifang Lv, Beibei Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
The next bastion to be conquered in immunotherapy: microsatellite stable colorectal cancer
Kai Ding, Pei Mou, Zhe Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment
Xing He, Huanrong Lan, Ketao Jin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Instigation of the epoch of nanovaccines in cancer immunotherapy
Saurabh Shah, Paras Famta, Vinod K. Tiwari, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 15, Iss. 3
Open Access | Times Cited: 10
Tissue adhesive indocyanine green‐locking granular gel‐mediated photothermal therapy combined with checkpoint inhibitor for preventing postsurgical recurrence and metastasis of colorectal cancer
Yuan Zeting, Shuli Ma, Yue Li, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 6
Open Access | Times Cited: 5
Unveil the mechanism for EHMT -- A novel triterpenoid inhibits proliferation and induces apoptosis in colon cancer through ROS-mediated JNK signaling pathway
Qiushuang Wu, Min Song, Siyuan Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116469-116469
Open Access | Times Cited: 1
Matrine impedes colorectal cancer proliferation and migration by downregulating endoplasmic reticulum lipid raft associated protein 1 expression
Hongtao Ren, Yali Wang, Ya Guo, et al.
Bioengineered (2022) Vol. 13, Iss. 4, pp. 9780-9791
Open Access | Times Cited: 7
Intestinal Microbiota: The Driving Force behind Advances in Cancer Immunotherapy
Zhujiang Dai, Jihong Fu, Xiang Peng, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4796-4796
Open Access | Times Cited: 4
Activation of STING by the Novel Liposomal TLC388 Enhances the Therapeutic Response to Anti-PD-1 Antibodies in Combination with Radiotherapy
Jhen-Yu Chen, Po‐Yu Lin, Wei-Ze Hong, et al.
Research Square (Research Square) (2024)
Open Access
RNA Modifications as a Therapeutic Target in Gastrointestinal Cancer: Exploring Emerging Opportunities
Haiyun Shang, Xiaoting Zhang, Hao Su, et al.
Interdisciplinary cancer research (2024)
Closed Access
Shengqiyichang Decoction regulates antitumor immunity in colorectal cancer by downregulating lymphocyte antigen 6 family member G6D via the protein kinase B/p38 mitogen-activated protein kinase signaling pathway
Run Xing Luo, Huai Liang Li, Yu Jia, et al.
Heliyon (2024) Vol. 10, Iss. 21, pp. e39071-e39071
Open Access
Page 1 - Next Page

Scroll to top